Patent Ductus Arteriosus: Increased Risk of Bronchopulmonary Dysplasia?

被引：0
|
作者：
Bancalari, E. [1 ]
机构：
[1] Univ Miami, Miller Sch Med, Dept Pediat, Div Neonatol, Miami, FL 33136 USA
来源：
NEONATOLOGY | 2014年 / 106卷 / 03期
关键词：
CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; PRETERM INFANTS; PULMONARY-HYPERTENSION; CONTROLLED-TRIAL; INDOMETHACIN; EXPRESSION; IBUPROFEN; PLACEBO; CLOSURE;
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
14
引用
收藏
页码：274 / 275
页数：2
相关论文
共 50 条
  • [21] PATENT DUCTUS ARTERIOSUS AND BRONCHOPULMONARY DYSPLASIA ASSOCIATED PULMONARY HYPERTENSION: A CASE CONTROL STUDY
    Gentle, S. J.
    Travers, C.
    Pearce, B.
    Carlo, W. A.
    Ambalavanan, N.
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2022, 70 (02) : 618 - 618
  • [22] 949 Risk of Bronchopulmonary Dysplasia (BPD) is Increased After Surgical Ligation of Ductus Arteriosus in Preterm Infants
    J H Jeon
    R Namgung
    M S Park
    K I Park
    C Lee
    [J]. Pediatric Research, 2010, 68 : 474 - 474
  • [23] Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia
    Ansems, Sophia M.
    Kirpalani, Haresh
    Mercer-Rosa, Laura
    Wang, Yan
    Hopper, Rachel K.
    Fraga, Maria, V
    Jensen, Erik A.
    [J]. NEONATOLOGY, 2019, 116 (03) : 236 - 243
  • [24] Why does indomethacin prophylaxis prevent patent ductus arteriosus (PDA), but not bronchopulmonary dysplasia (BPD)?
    Schmidt, B
    Roberts, RS
    Fanaroff, A
    Davis, P
    Kirpalani, HM
    Nwaesei, C
    Vincer, M
    [J]. PEDIATRIC RESEARCH, 2003, 53 (04) : 354A - 354A
  • [25] Patent ductus arteriosus, bronchopulmonary dysplasia and pulmonary hypertension-a complex conundrum with many phenotypes?
    EL-Khuffash, Afif
    Mullaly, Rachel
    McNamara, Patrick J. J.
    [J]. PEDIATRIC RESEARCH, 2023, 94 (02) : 416 - 417
  • [26] Hemodynamically significant ductus arteriosus and bronchopulmonary dysplasia Reply
    Francescato, Gaia
    Schena, Federico
    Mosca, Fabio
    [J]. JOURNAL OF PEDIATRICS, 2015, 167 (05): : 1175 - 1175
  • [27] Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
    Clyman, Ronald I.
    Hills, Nancy K.
    [J]. SEMINARS IN PERINATOLOGY, 2023, 47 (02)
  • [28] Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: Further analyses from the trial of indomethacin prophylaxis in preterms (TIPP)
    Schmidt, Barbara
    Roberts, Robin S.
    Fanaroff, Avroy
    Davis, Peter
    Kirpalani, Haresh M.
    Nwaesei, Chuks
    Vincer, Michael
    [J]. JOURNAL OF PEDIATRICS, 2006, 148 (06): : 730 - 734
  • [29] Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis
    Villamor, Eduardo
    van Westering-Kroon, Elke
    Gonzalez-Luis, Gema E.
    Bartos, Frantisek
    Abman, Steven H.
    Huizing, Maurice J.
    [J]. JAMA NETWORK OPEN, 2023, 6 (11)
  • [30] Medical closure of patent ductus arteriosus does not reduce mortality and development of bronchopulmonary dysplasia in preterm infants
    Terek, Demet
    Yalaz, Mehmet
    Ulger, Zulal
    Koroglu, Ozge Altun
    Kultursay, Nilgun
    [J]. JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 (11): : 1074 - 1079
12345